Mh. Wu et al., Lack of evidence for a polymorphism at codon 160 of human O-6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer, CLIN CANC R, 5(1), 1999, pp. 209-213
O-6-benzylguanine (BG) is a potent, specific inactivator of the DNA repair
protein O-6-alkylguanine-DNA alkyltransferase (AGT), which enhances sensiti
vity to nitrosoureas in cells and tumor-bearing animals. BG is presently un
dergoing clinical trials for development as an agent to enhance the therape
utic index of alkylating agent chemotherapy, It has been reported that a po
lymorphism exists in the human agt gene, with about 15% of the Japanese pop
ulation having arginine at codon 160 instead of glycine on the polypeptide
(Y, Imai ef al,, Carcinogenesis, 16: 2441-2445, 1995), The resultant mutant
AGT protein is equally effective against both methylated DNA as compared w
ith wild type protein. However, this mutant AGT protein was less sensitive
to inactivation by BG with a 20-fold increase in the ED50 value. This obser
vation raised the possibility that a subpopulation of patients may be resis
tant to BG due to a single base change. We have demonstrated that this alte
ration also reduces the sensitivity to O-6-benzyl-8-oxoguanine, an equally
potent, yet much longer-lived human metabolite of BG, To test the possibili
ty that this germ-line mutation of the agt gene might explain resistance to
BG and O-6-benzyl-8-oxoguanine of patients on our Phase I clinical trials,
we evaluated the DNA from lymphocytes of 18 patients. The G160R mutation w
as not found in any of the 18 patients. To determine the frequency of this
mutation in the United States population, DNA from 181 healthy individuals
were investigated and, again, the mutation was not observed in this cohort.
Therefore, if the mutation exists, it is in statistically <1.6% of the Uni
ted States noncancerous population. To investigate the possibility that thi
s mutation might be somatic, we evaluated genomic DNA samples from 94 human
primary cancers of four different histological subtypes (brain, colon, eso
phageal, and head and neck). Again, none were found to have the G160R mutat
ion.